Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Phase II, Randomised, Double-blind, Placebo-controlled, Parallel-group Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine

NCT04102995 is registered in ClinicalTrials.gov with Asarina Pharma as lead sponsor.

NCT NCT04102995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04102995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Phase II, Randomised, Double-blind, Placebo-controlled, Parallel-group Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine
Lead sponsor
Asarina Pharma
Phase
Phase 2
Overall status
Completed
Start date
August 27, 2019
Completion date
May 15, 2021
Enrollment
86 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

menstrual migraine